2nd Quarter - Report — HARM REDUCTION COALITION for HARM REDUCTION COALITION (2012)

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm

HARM REDUCTION COALITION

Client

HARM REDUCTION COALITION

Income

—

Expenses

$20,000

Expense method

A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing	Filed	Amount	Counted
2nd Quarter - Report (this page)	Aug 7, 2012	$20,000	Replaced
2nd Quarter - Report	Oct 23, 2012	$20,000	Yes

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Access to naloxone Opioid overdose prevention Viral Hepatitis Testing Act of 2011 Over turning the federal funding ban on syringe exchange services

Lobbyist	Covered position, as disclosed
WHITNEY ENGLANDER	—

Contacted: Natl Institutes of Health (NIH); Substance Abuse & Mental Health Services Administration (SAMHSA); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Centers For Disease Control & Prevention (CDC); SENATE; Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.